| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/04/2003 | CN1422252A Chemokine receptor antagonists |
| 06/04/2003 | CN1422249A Novel alpha-sulfin-and alpha-sulfonamino acid amides |
| 06/04/2003 | CN1110497C Di-or triaza-spiral [4,5] decane derivative |
| 06/03/2003 | USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof |
| 06/03/2003 | USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease |
| 06/03/2003 | US6573404 Intermediates in industrial organic synthesis, e.g. in the preparation of fine chemicals, dyes and crop-protection compositions |
| 06/03/2003 | US6573395 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine)) |
| 06/03/2003 | US6573345 Late transition metal pyrrolaldimine chelates, especially bidentate |
| 06/03/2003 | US6573294 Method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound |
| 06/03/2003 | US6573293 Anticancer agents |
| 06/03/2003 | US6573267 Central nervous system disorders |
| 06/03/2003 | CA2123083C Uses of 1,1,1,3,3,3-hexafluoropropane |
| 05/30/2003 | WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/30/2003 | WO2003044011A1 Pyrrole synthesis |
| 05/30/2003 | WO2003043985A1 Heterocyclic compounds and methods of use |
| 05/30/2003 | WO2003043984A1 Gabusectin derivatives, method for the production thereof and use of the same |
| 05/30/2003 | WO2003043983A1 Piperazine derivatives destabilising androgen receptors |
| 05/30/2003 | WO2003043982A1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 05/30/2003 | WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 05/30/2003 | WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 05/30/2003 | WO2003043656A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 05/30/2003 | WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 05/30/2003 | WO2003005824B1 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators |
| 05/30/2003 | WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof |
| 05/30/2003 | WO2002016313A3 Integrin receptor inhibitors |
| 05/30/2003 | CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 05/30/2003 | CA2467251A1 Gabusectin derivatives, method for the production thereof and use of the same |
| 05/30/2003 | CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/30/2003 | CA2464314A1 Pyrrole synthesis |
| 05/29/2003 | US20030100770 D-proline derivatives |
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/29/2003 | US20030100750 Process for solid supported synthesis of pyruvate-derived compounds |
| 05/29/2003 | US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands |
| 05/29/2003 | US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders |
| 05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 05/29/2003 | US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells |
| 05/29/2003 | US20030100441 Polymerization of olefin |
| 05/28/2003 | EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 05/28/2003 | EP1241986A4 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 05/28/2003 | EP1100777B1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents |
| 05/28/2003 | EP0788360B1 Boronic ester and acid compounds, synthesis and uses |
| 05/28/2003 | CN1109544C Beta-alkoxyacrylates against malaria |
| 05/28/2003 | CN1109499C Fungicide active substance combinations |
| 05/27/2003 | US6570024 N-methyl-L-alanine derivatives derivatives used for preparing cell binding agent/maytansinoid complexes |
| 05/27/2003 | US6569972 Photo-alignment materials for liquid crystal alignment film |
| 05/27/2003 | US6569890 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/27/2003 | US6569889 Anticarcinogenic agents |
| 05/27/2003 | US6569863 Bicyclic heteroamatic compounds useful as LH agonists |
| 05/27/2003 | US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity |
| 05/27/2003 | US6569356 Chiral compounds and their use as doping agents in liquid crystals |
| 05/22/2003 | WO2003042173A1 Nk1 antagonists |
| 05/22/2003 | WO2003018004A3 Analgetic pyrroline derivatives |
| 05/22/2003 | WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | US20030097006 Methods of making pyrrolidones |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/22/2003 | US20030096989 Refined routes to chlorin building blocks |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030096857 Novel antidiabetic agents |
| 05/22/2003 | US20030096842 Inhibitors of farnesyl protein transferase |
| 05/22/2003 | US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function |
| 05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/22/2003 | US20030096806 For use as pesicides, herbicides; crop protection |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/22/2003 | US20030095985 Immunogenic conjugates of Gram-negative bacterial autoinducer molecules and antibodies raised against the same |
| 05/22/2003 | CA2466465A1 Nk1 antagonists |
| 05/21/2003 | EP1312609A1 Boronic ester and acid compounds, synthesis and uses |
| 05/21/2003 | EP1312600A1 Process for separating mixtures of crude, water-containing amines originating from the amine synthesis |
| 05/21/2003 | EP1312599A1 Process for separating mixtures of crude, water-containing amines originating from the amine synthesis |
| 05/21/2003 | EP1311518A1 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts |
| 05/21/2003 | EP1311499A2 Bicyclic compounds as h3 receptor ligands |
| 05/21/2003 | EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 05/21/2003 | EP1311481A1 Process for preparing distamycin derivatives |
| 05/21/2003 | EP1311480A1 New amidino derivatives and their use as thrombin inhibitors |
| 05/21/2003 | EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 05/21/2003 | EP1311475A1 Novel aminocyclohexane derivatives |
| 05/21/2003 | EP1311471A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 05/21/2003 | EP1311255A1 Compounds having mif antagonist activity |
| 05/21/2003 | EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/21/2003 | CN1419553A Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 05/21/2003 | CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 05/21/2003 | CN1419534A Diphenyl ether compounds useful in therapie |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/21/2003 | CN1109031C Bicycle-aromatic compound |
| 05/21/2003 | CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 05/20/2003 | US6566553 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline |
| 05/20/2003 | US6566533 Reacting aza-heterocyclic compounds (indoles and carbazoles) with alkyl- or aryl-halides in the presence of carbon dioxide and alkali carbonate |
| 05/20/2003 | US6566525 Preparation of N-substituted-hydroxycycloalkylamine derivatives |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566384 For therapy of cancer, inflammation and inflammatory diseases, tissue degeneration, periodontal disease, ophthalmological disease, dermatological disorders, fever, cardiovascular effects, haemorrhage, coagulation and acute phase response |
| 05/20/2003 | US6566118 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 05/20/2003 | US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein |
| 05/20/2003 | US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric |
| 05/20/2003 | CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers |
| 05/20/2003 | CA2110693C Amino acid derivative anticonvulsant |
| 05/20/2003 | CA2091668C Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles |
| 05/15/2003 | WO2003040337A2 Polyamide modulators of cox2 transcription |
| 05/15/2003 | WO2003040288A2 Isotopically coded affinity markers 3 |
| 05/15/2003 | WO2003040133A1 Maleic acid derivative and curable composition containing the same |